Depression
From the Journals
Lifeline calls spike after Robin Williams’ suicide
The average number of daily suicides also dramatically increased.
From the Journals
Depression treatment rates rose with expanded insurance coverage
Total spending on outpatient depression treatment increased from $12,430,000 in 1998 to $15,554,000 in 2007, and $17,404,000 in 2015.
Conference Coverage
Anxiety, not depression, commonly afflicts euthyroid patients with thyroid disease
LOS ANGELES – Clinicians should focus on signs of anxiety symptoms in euthyroid patients with thyroid disease who report psychosomatic impairments...
News
FDA modifies safety label for Addyi
The boxed warning no longer suggests total abstinence from alcohol.
Commentary
My patient will die
Dr. Ruth Cohen describes meeting with a patient who is facing terminal illness.
Opinion
Depression: a changing concept in the age of ketamine
If a patient’s depression is alleviated in an hour, was it really clinical depression? Is it truly in remission? ask Dr. Nicolas Badre and Dr....
From the Journals
In utero infections raise risk for autism
Conference Coverage
Anxiety, depression compromise believability of drug-allergy testing
SAN FRANCISCO – Drug-allergy testing often produces a negative result, but some patients have a hard time believing...
From the Journals
fMRI might help differentiate MDD and bipolar disorder
Major depressive disorder and bipolar disorder appear to be associated with different underlying brain structures.
Commentary
IV ketamine, intranasal esketamine likely to ‘happily coexist’
“Initially, not every psychiatrist will be able to offer esketamine ... and that’s probably okay.”
Latest News
FDA approves intranasal esketamine for refractory major depressive disorder
Under the FDA-required REMS, prescribers must complete specific training; the drug must be adminstered in office to allow for patient monitoring...